Hillsdale Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-510
| Closed | -$420K | – | 635 |
|
|
2023
Q3 | $420K | Sell |
510
-30
| -6% | -$24.7K | 0.04% | 307 |
|
|
2023
Q2 | $388K | Buy |
+540
| New | +$388K | 0.04% | 299 |
|
|
2022
Q2 | – | Sell |
-40
| Closed | -$28K | – | 608 |
|
|
2022
Q1 | $28K | Sell |
40
-1,000
| -96% | -$700K | ﹤0.01% | 495 |
|
|
2021
Q4 | $657K | Buy |
+1,040
| New | +$657K | 0.04% | 331 |
|
|
2020
Q4 | – | Sell |
-765
| Closed | -$428K | – | 649 |
|
|
2020
Q3 | $428K | Hold |
765
| – | – | 0.04% | 356 |
|
|
2020
Q2 | $477K | Sell |
765
-200
| -21% | -$125K | 0.04% | 332 |
|
|
2020
Q1 | $471K | Sell |
965
-355
| -27% | -$173K | 0.06% | 302 |
|
|
2019
Q4 | $496K | Hold |
1,320
| – | – | 0.04% | 361 |
|
|
2019
Q3 | $366K | Hold |
1,320
| – | – | 0.03% | 393 |
|
|
2019
Q2 | $413K | Hold |
1,320
| – | – | 0.04% | 375 |
|
|
2019
Q1 | $542K | Buy |
1,320
+20
| +2% | +$8.21K | 0.05% | 282 |
|
|
2018
Q4 | $486K | Hold |
1,300
| – | – | 0.06% | 212 |
|
|
2018
Q3 | $525K | Hold |
1,300
| – | – | 0.07% | 167 |
|
|
2018
Q2 | $448K | Buy |
+1,300
| New | +$448K | 0.06% | 207 |
|